Yes, the document I linked to is a proposal submitted jointly by the parties.
From MNTA’s standpoint, there is no impetus to rush the discovery in this case because the status quo in the US Lovenox market could not possibly be better.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”